Preventive Ethics: Summary of VISN Cross-Cutting Ethics Issues Directions: The purpose of the Summary of VISN Cross-Cutting Ethics Issues tool is to provide a concise snapshot of a completed project. One tool should be completed for each cross-cutting ethics issue addressed. VISN Number: First name: Last name: Identify the VISN POC: Contact information: Improving Adherence to Informed Consent for Long-term Opioid Therapy for Non-cancer Pain Provide a working title for this cross-cutting ethics issue: Quarter/Fiscal Year completed: As prescriptions for opioids in the United States have increased significantly over the past 20 years, so have opioid-related problems such as co-prescribing with sedative hypnotics, multiple prescriptions, opioids misuse, increased litigations and unclear effectiveness of long term opioid therapy. Provide a brief description of the ethics issue that was addressed: In May 2014, VHA Directive 1005 Informed Consent for Long-Term Opioid therapy for Pain was issued which developed a standardized patient-centered information guide and signature (i.e., who, what, where, when, how much or consent form which will replace all pain agreements. how often?) VHA Handbook 1004.01 Informed Consent for Clinical Treatments and Procedures, August 2009
Preventive Ethics: Summary of VISN Cross-Cutting Ethics Issues Directions: The purpose of the Summary of VISN Cross-Cutting Ethics Issues tool is to provide a concise snapshot of a completed project. One tool should be completed for each cross-cutting ethics issue addressed. VISN Number: Identify the VISN POC: First name: Last name: Contact information: Provide a working title for this cross-cutting ethics issue: Improving Adherence to Informed Consent for Long-term Opioid Therapy for Non-cancer Pain Quarter/Fiscal Year completed: Provide a brief description of the ethics issue that was addressed: (i.e., who, what, where, when, how much or how often?) As prescriptions for opioids in the United States have increased significantly over the past 20 years, so have opioid-related problems such as co-prescribing with sedative hypnotics, multiple prescriptions, opioids misuse, increased litigations and unclear effectiveness of long term opioid therapy. In May 2014, VHA Directive 1005 Informed Consent for Long-Term Opioid therapy for Pain was issued which developed a standardized patient-centered information guide and signature consent form which will replace all pain agreements. VHA Handbook 1004.01 Informed Consent for Clinical Treatments and Procedures, August 2009
opioid_cross_cutting_final_090415.docx